Page 58 - MAN. ABORDAJE 2° EDICION FINAL

36. Grider JS, Mullet TW, Saha SP, Harned ME, Sloan PA. A randomized, double-blind trial comparing continuous thoracic epidural
bupivacaine with and without opioid in contrast to a continuous paravertebral infusion of bupivacaine for post-thoracotomy
pain. J Cardiothorac Vasc Anesth. 2012 Feb;26(1):83-9.
37. Schwartzmann A, Peng P, Maciel MA, Forero M. Mechanism of the erector spinae plane block: insights from a magnetic
resonance imaging study. Can J Anesth. 2018;65(10):1165–6.
38. Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, editors. Miller. Anestesia: octava edición. Elsevier; 2015.
39. Arumugam S, Lau CS, Chamberlain RS. Use of preoperative gabapentin significantly reduces postoperative opioid consumption:
a meta-analysis. J Pain Res. 2016 Sep 12;9:631-40.
40. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T et al. Management of Postoperative Pain: A
Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine,
and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative
Council. J Pain. 2016 Feb;17(2):131-57.
41. Jain HN, Patel PP, Gohel MR, Upadhyay UM. Formulation And Evaluation Of Pregabalin Sustained Release Tablets. IAJPS.
2016;3(11),1316-1321.
42. Huffman CL, Goldenberg JN, Weintraub J, Sanin L, Driscoll J, Yang R. Efficacy and Safety of Once-Daily Controlled-Release
Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized
Withdrawal, Placebo-Controlled Trial. Clin J Pain. 2017 Jul;33(7):569-578.
43. Srivastava A, Shah S, Maseeh A, Vyasa B, Balaji M, Bhatter S et al. A clinical study to compare the efficacy and safety of
pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral
neuropathic pain. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S477-9.
44. Kong VK, Irwin MG. Gabapentin: a multimodal perioperative drug? Br J Anaesth. 2007 Dec;99(6):775-86.
45. Ho KY1, Gan TJ, Habib AS. Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain.
2006 Dec 15;126(1-3):91-101.
46. Schmidt PC, Ruchelli G, Mackey SC, Carroll IR. Perioperative gabapentinoids: choice of agent, dose, timing, and effects on
chronic postsurgical pain. Anesthesiology. 2013 Nov;119(5):1215-21.
47. Tratamiento del cancer, manejo del dolor. Instrucciones para pacientes. Biblioteca Nacional de Medicina de los Estados
Unidos.2014.
48. Merskey H, Bogduk N. Pain Terms. A Current List with Definitions and Notes on Usage. Classification of Chronic Pain, 2 Ed,
IASP Task Force on Taxonomy. 1994.
49. 46. Armstrong L, Goldman M, et al. Drug Information Handbook. 8th ed. American Pharmaceutical Association.
50. Loza E. AINEs en la practica clinica: lo que hay que saber. Inf Ter del Sist Nac Salud. 2011; 35 (3):88–95.
51. ADAPT Research Group. Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer’s Disease
Antiinflammatory Prevention Trial (ADAPT). PLos Clin Trials 2006; 1(7): e33.
52. Bombadier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with
rheumatoid arthritis. The Vioxx and Gastrointestinal Outcomes (VIGOR) Trial. N Engl J Med 2000; 343: 1520-1528.
53. Sergey M. Motov. Dosing Opioids for Optimal Acute Pain Management. Medscape. Apr 26, 2010. Disponible en: http://www.
medscape.com/viewarticle/720539
54. Wall PD, Melzack R. Textbook of pain. 6th Ed. Churchill Livingstone; 2013.
55. Safe Anaesthesia Liasion Group. Intravenous Paracetamol [Internet]. 2013. Disponible en: www.aagbi.org/sites/default/files/
intravenousparacetamol.pdf
56. De Leeuw TG, Dirckx M, Gonzalez Candel A, Scoones GP, Huygen FJPM, de Wildt SN. The use of dipyrone (metamizol) as an
analgesic in children: What is the evidence? A review. Paediatr Anaesth. 2017 Dec;27(12):1193-1201.
57. Schuchen RH, Mucke M, Marinova M, Kravchenko D, Hauser W, Radbruch L, Conrad R. Systematic review and meta-analysis
on non-opioid analgesics in palliative medicine. J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1235-1254.
58. Aubrun F., Mazoit J.-X., Riou B. Postoperative intravenous morphine titration. British Journal of Anaesthesia. 2012 (2), pp. 193-201.
59. National Comprehensive Cancer Network. NCCN Guidelines Version 2. 2016: Adult Cancer Pain.
60. Bravo L, Mico JA, Berrocoso E. Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov.
2017 Dec;12(12):1281-1291.
61. David Aso. Exploracion neurologica basica para fisioterapeutas. [Internet]. FisioAso Neuroblog; 2013 [acceso 8 de abril de 2016].
Disponible en: http://davidaso.fisioterapiasinred.com/2013/12/exploracion-neurologica-basica-para-fisioterapeutas.html
62. U.S. Food and Drug Administration. New steps aimed at cutting risk from acetaminophen. FDA consumer health information
[Internet]. Disponible en: www.fda.gov/consumer/
63. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005 Jan-Feb;12(1):46-55.
64. Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) [Internet]. Disponible en: http://www.aemps.gob.es/
65. Gollamudi J, Marks S. Oral versus Intravenous Acetaminophen #302. J Palliat Med. 2016 Feb;19(2):231-2.
66. Singla NK, Parulan C, Samson R, Hutchinson J, Bushnell R, Beja EG, et al. Plasma and cerebrospinal fluid pharmacokinetic
parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract. 2012 Sep;12(7):523-32.
67. Jahr JS, Lee VK. Intravenous acetaminophen. Anesthesiol Clin. 2010 Dec;28(4):619-45.
68. Jean-Louis V, Edward A, Patrick K, Frederick M, Mitchell F. Textbook of critical care, sixth edition, chapter 183, pags.1346-1353, 2011.
69. Carlo P. Non steroidal anti inflammatory drugs. En: Rheumatology, sixth edition, chapter 4, edit. Mosby, 2015.
70. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal
antiinflammatory drugs (NSAIDs) can cause heart attacks or strokes [Internet]. Disponible en: http://www.fda.gov/Drugs/
DrugSafety/ucm451800.htm
71. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal
antiinflammatory drugs: network meta-analysis. BMJ. 2011 Jan 11;342:c7086.
72. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview
of Cochrane reviews. Cochrane Database Syst Rev. 2015 Nov 4;11:CD010794.
73. Buitrago Gonzalez TP, Calderon Ospina CA, Vallejos Narvaez A. Dipirona: .Beneficios subestimados o riesgos sobredimensionados?
Revision de la literatura Revista Colombiana de Ciencias Quimico Farmaceuticas. 2014 Jan; 43 (1):173-195.
74. Jasiecka A, Ma lanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014;17(1):207-14.
75. Ibanez L, Vidal X, Ballarin E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol. 2005
Jan;60(11):821-9.B.
76. Bar-Oz B, Clementi M, Di Giantonio E, Greenberg R, Beer M, Merlob P, Arnon J, Ornoy A, Zimmerman DM, Berkovitch M.
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol.
2005 Apr 1;119(2):176-9.
77. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al.; American Society of Interventional Pain Physicians.
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer
pain: Part 2--guidance. Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
78. Johnson SJ. Opioid safety in patients with renal or hepatic dysfunction. Pain treatment topics. 2007 Jun 1;6(1):1.

58